PRENW | Prenetics Global Limited Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.0102 - 0.0103
52 Week Range	0.0102 - 0.0103
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	12
Average Volume	N/A
Shares Outstanding	5,389,952,745
Market Cap	54,977,518
Sector	Healthcare
Industry	Medical - Diagnostics & Research
IPO Date	N/A

Valuation
Profitability
Growth
Health
P/E Ratio	N/A
Forward P/E Ratio	N/A
EPS	-11.04
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	320
Country	Hong Kong
Website	PRENW

Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

PRENW's peers: DRTSW, ROIVW, PIIIW, PROCW, EFTRW

*Chart delayed

Analyzing fundamentals for PRENW we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see PRENW Fundamentals page.

Watching at PRENW technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on PRENW Technicals page.